Skip to main content

Table 1 Baseline characteristics of patients with and without osteoporosis

From: Increased migraine risk in osteoporosis patients: a nationwide population-based study

Variables

Osteoporosis

P value

Yes (N = 40,672)

No (N = 40,672)

 

Migraine patients, n (%)

1110 (2.73)

751 (1.85)

<0.001

Period of developing migraine, median (IQR), years

3.5 (1.5–6.2)

7.2 (4.8–10.5)

<0.001

Mean age at diagnosis of migraine, years

57.9 (10.4)

62.6 (10.3)

<0.001

Age group, n (%)

   

 20–49

7361 (18.10)

7361 (18.10)

 

 ≥50

33,311 (81.90)

33,311 (81.90)

1.000

Gender, n (%)

   

 Men

7125 (17.52)

7125 (17.52)

 

 Women

33,547 (82.48)

33,547 (82.48)

1.000

Charlson Comorbidity Index, n (%)

   

 0

1912 (4.70)

7744 (19.04)

 

 1–2

9667 (23.77)

14,437 (35.50)

 

 3–4

11,911 (29.29)

9861 (24.25)

 

 ≥5

17,182 (42.25)

8630 (21.22)

<0.001

Co-morbidity, n (%)

   

 Hypertension

28,521 (70.12)

21,991 (54.07)

<0.001

 Diabetes mellitus

15,693 (38.58)

11,272 (27.71)

<0.001

 Hyperlipidemia

24,923 (61.28)

17,879 (43.96)

<0.001

 Depression

8625 (21.21)

4764 (11.71)

<0.001

 Asthma

11,700 (28.77)

7807 (19.20)

<0.001

 Allergic rhinitis

18,146 (44.62)

13,168 (32.38)

<0.001

 Psoriasis

874 (2.15)

583 (1.43)

<0.001

 Obesity

1073 (2.64)

857 (2.11)

<0.001

 Tobacco use disorder

776 (1.91)

422 (1.04)

<0.001

 Alcohol attributed disease

1069 (2.63)

780 (1.92)

<0.001

  1. IQR interquartile range, SD standard deviation